Research & Development Market Research Reports & Industry Analysis
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Research & Development Industry Research & Market Reports
-
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
... and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape ... Read More
-
Depression Treatment Drugs Industry Forecasts - China Focus
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Anti-Obesity Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Anti-Tumor Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Lymphoma Treatment Drugs Markets in China
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More
-
Depression Treatment Drugs Markets in China
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More
-
Global Nootropics Market 2022-2026
... on the nootropics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Medical Marijuana
... projected to reach a revised size of US$54 Billion by 2027, growing at aCAGR of 14.2% over the period 2020-2027. Extract Form, one of the segments analyzed in the report, is projected to record 14.6% ... Read More
-
Global Coronavirus Partnering 2015-2022
... deal terms for headline, upfront and royalty by stage of development Coronavirus partnering agreement structure Coronavirus partnering contract documents Top Coronavirus deals by value Most active Coronavirus dealmakers Most of the deals included within the ... Read More
-
Legal Marijuana
... projected to reach a revised size of US$66.3 Billion by 2027, growing at aCAGR of 22.5% over the period 2020-2027. Oil & Tinctures, one of the segments analyzed in the report, is projected to record ... Read More
-
Contract Research Outsourcing
... year 2020, is projected to reach a revised size of US$72.1 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Clinical, one of the segments analyzed in the report, is ... Read More
-
Non-alcoholic Steatohepatitis (NASH)
... year 2020, is projected to reach a revised size of US$39.5 Billion by 2027, growing at a CAGR of 53.2% over the analysis period 2020-2027. Vitamin E & Pioglitazone, one of the segments analyzed in ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... Billion in the year 2020, is projected to reach a revised size of US$4.6 Billion by 2027, growing at a CAGR of 22.2% over the analysis period 2020-2027. Cardiac Glycosides, one of the segments analyzed ... Read More
-
Melanoma Therapeutics
... a revised size of US$10.1 Billion by 2027, growing at a CAGR of 14.6% over the analysis period 2020-2027. Cutaneous Melanoma, one of the segments analyzed in the report, is projected to record a 14.7% ... Read More
-
Colorectal Cancer Therapeutics
... projected to reach a revised size of US$18 Billion by 2027, growing at a CAGR of 6.3% over the analysis period 2020-2027. Targeted Therapy, one of the segments analyzed in the report, is projected to ... Read More
-
HIV Drugs
... a revised size of US$45.4 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Combination HIV Medicines, one of the segments analyzed in the report, is projected to record a ... Read More
-
Cannabis Testing
... a revised size of US$2.8 Billion by 2027, growing at a CAGR of 12.9% over the analysis period 2020-2027. Services, one of the segments analyzed in the report, is projected to record a 14.7% CAGR ... Read More
-
CBD Gummies
... projected to reach a revised size of US$14.8 Billion by 2027, growing at aCAGR of 30.1% over the period 2020-2027. Low, one of the segments analyzed in the report, is projected to record 29.5% CAGR ... Read More
-
Genitourinary Drugs
... projected to reach a revised size of US$28.9 Billion by 2027, growing at a CAGR of 0.5% over the analysis period 2020-2027. Urologicals, one of the segments analyzed in the report, is projected to record ... Read More
-
CBD Nutraceuticals
... projected to reach a revised size of US$22.7 Billion by 2027, growing at a CAGR of 17.7% over the analysis period 2020-2027. CBD Tinctures, one of the segments analyzed in the report, is projected to ... Read More
-
Acne Drugs
... projected to reach a revised size of US$13.7 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Inflammatory, one of the segments analyzed in the report, is projected to record ... Read More
-
Contract Research Organization Services (CROs)
... estimated at US$54 Billion in the year 2020, is projected to reach a revised size of US$102.8 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. Early Phase Development, one ... Read More
-
In Vivo Contract Research Organization (CRO)
... Research Organization (CRO) estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at aCAGR of 8% over the period 2020-2027. Rodend-based, one of ... Read More
-
In Vivo Toxicology
... year 2020, is projected to reach a revised size of US$7.7 Billion by 2027, growing at aCAGR of 6.3% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to ... Read More
-
Global Dental Partnering 2010-2022: Deal trends, players and financials
... in Dental partnering deals Financial deal terms for headline, upfront and royalty by stage of development Dental partnering agreement structure Dental partnering contract documents Top Dental deals by value Most active Dental dealmakers Most of ... Read More
Research Assistance
